US EditionBioNTech stops making cell therapy at Maryland site after dropping germ cell tumor indication
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
BioNTech stops making cell therapy at Maryland site after dropping germ cell tumor indication
BioNTech said it's stopping work on an experimental cell therapy in certain indications, and is winding down cell therapy manufacturing at its Gaithersburg, MD site. “We have made the difficult decision to discontinue cell therapy ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
